SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

09 Feb 2022 Evaluate
The revenue for the December 2021 quarter is pegged at Rs. 2779.00 millions, about 15.69% up against Rs. 2402.20 millions recorded during the year-ago period.A big decline of -33.94% was reported for the quarter ended December 2021 to Rs. 448.40  millions from Rs. 678.80 millions of corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 665.40 millions from 944.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202106 202006 % Var
Sales 2779.00 2402.20 15.69 5507.00 5041.90 9.22 10087.30 8911.96 13.19
Other Income 47.00 57.20 -17.83 77.40 124.40 -37.78 181.00 337.27 -46.33
PBIDT 665.40 944.70 -29.56 1476.50 1792.90 -17.65 2641.20 2444.80 8.03
Interest 1.20 1.90 -36.84 2.60 4.30 -39.53 8.00 0.00 0.00
PBDT 664.20 942.80 -29.55 1473.90 1788.60 -17.59 2633.20 2444.80 7.71
Depreciation 65.90 78.50 -16.05 134.90 152.10 -11.31 300.40 206.18 45.70
PBT 598.30 864.30 -30.78 1339.00 1636.50 -18.18 2332.80 2238.62 4.21
TAX 149.90 185.50 -19.19 336.90 365.10 -7.72 564.80 545.70 3.50
Deferred Tax 1.00 -4.80 -120.83 -5.00 -14.10 -64.54 -49.00 94.90 -151.63
PAT 448.40 678.80 -33.94 1002.10 1271.40 -21.18 1768.00 1692.92 4.43
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 23.94 39.33 -39.12 26.81 35.56 -24.60 26.18 27.43 -4.55

Procter&Gamble Healt Share Price

5021.30 29.00 (0.58%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×